Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time.
about
Clinical and laboratory update on the DEL variantCurrent problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group.An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012.Red cell alloimmunisation: incidence and preventionWeak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.Molecular genetics and clinical applications for RH.DNA-based methods in the immunohematology reference laboratory.It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.Integration of red cell genotyping into the blood supply chain: a population-based study.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013Implementing mass-scale red cell genotyping at a blood centerExternal quality assessment in molecular immunohematology: the INSTAND proficiency test program.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015A model for integrating molecular-based testing in transfusion services.Scianna: the lucky 13th blood group system.Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand.Prospects for the provision of genotyped blood for transfusion.Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.Molecular polymorphisms of human blood groups: a universe to unravel.Duffy and kidd genotyping facilitates pretransfusion testing in patients undergoing long-term transfusion therapy.Red cell genotyping precision medicine: a conference summary.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Philadelphia 2014.ABO genotyping: the quest for clinical applications.A rewarding fresh look at routine blood group data.Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles.The future of red blood cell alloimmunization risk reduction.Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.DEL phenotype.Molecular typing for blood group antigens within 40 min by direct polymerase chain reaction from plasma or serum.PCR-free blood group genotyping using a nanobiosensor.Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype.
P2860
Q27022676-9F14C6D4-836B-499B-B39D-CC105E196A4CQ33393730-E7F2CFB5-1760-4B7F-A78B-C7D60D9DAF89Q33690889-098A45F3-2304-4B9F-B8D0-87A0A8DD408FQ33690911-2550644E-C9F4-48B9-8891-D9C05E1909E9Q33851247-68768C9B-DB8F-4E0C-B083-F658DE0A1B72Q34132155-4107CB1D-1F5D-459E-AA26-D47E5FDE43C0Q34282269-5630C52C-22BB-4E3B-8693-1F53EDBC5AA7Q34590286-8B4D64AE-B900-4C72-8714-155E035020FBQ34679079-927B75A8-601E-41C2-A342-F4DBF56100D7Q35171108-78C819A0-4607-4C52-A7AB-35E7D6080B56Q35867613-0E658886-86A1-45EC-B2D6-5ABEF0FE8741Q36187389-26F23F12-1EE1-4779-8299-40F87E3F916DQ36277665-B3E65F3C-779F-48A8-BB26-E02128494F19Q37315703-A3507318-F91D-47C7-83D5-A981B34DFD34Q37417326-3C549AE4-9F22-4271-9DA0-BE73DCAAAF83Q37417329-036ACE3C-8335-4EE8-9C85-2BD0B96A8C4DQ37536020-757D910B-389C-4CB7-A39E-6F0CC592F777Q37588930-E1315F7C-D542-4F66-A763-DEC0AF1E3D7FQ38124402-0DDA0BD9-1393-4747-9E33-B207FBAD33C2Q38855953-1503FA7B-B9D9-4C16-B1A2-2C42C317195DQ39309164-C23CED65-741D-436D-95BF-5E71438EDEA7Q41786692-28072BE7-7ABF-4D08-AEAF-36C0F30838D8Q41820533-FEE1ABED-D8C3-45A7-8B1A-EC503580F2A8Q42375642-4FA591ED-643D-4B61-944F-6D95E30E0E83Q42396851-D6B11700-07FE-4C48-9FE7-40F9AD363778Q43051362-92A051C8-D8ED-4E73-AFF6-5B33BBE95EACQ43198106-35BEDEF0-F483-472B-909B-82E5CFD8E8F0Q44031986-CA414E54-2079-46A3-9D68-D30A887D8F5CQ44451067-369ABF57-7B2C-4A01-8E5A-D40B8BE1CE1DQ46442270-06E3F093-F3A8-4B37-B2C0-A3305F9A0A51Q46990348-90DBB40A-38B0-48C8-9CFC-8C14AF64C1CDQ48141047-CEB564A1-DC83-42BD-B7EA-3B0624680611Q50455912-54E2E1B6-7B90-429E-A443-DEE29FA35B31Q51412052-0C5A8F0A-3EE1-4717-A4E7-1A29C659EEFAQ54325281-01EB8C4E-D2ED-422F-8D38-76E3F66CA3D1
P2860
Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Applying molecular immunohemat ...... blood banks: now is the time.
@en
type
label
Applying molecular immunohemat ...... blood banks: now is the time.
@en
prefLabel
Applying molecular immunohemat ...... blood banks: now is the time.
@en
P1433
P1476
Applying molecular immunohemat ...... blood banks: now is the time.
@en
P2093
Gregory A Denomme
Willy A Flegel
P2860
P304
P356
10.1111/J.1537-2995.2008.01855.X
P577
2008-11-01T00:00:00Z